Tudor Investment Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tudor Investment Corp’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,303,844	Closed	-$151M	–	3045
2023 Q3	$151M	Buy	1,303,844 +39,331	+3%	+$4.23M	1.51%	6
2023 Q2	$130M	Buy	1,264,513 +186,368	+17%	+$19.7M	1.55%	2
2023 Q1	$118M	Buy	1,078,145 +429,473	+66%	+$47.5M	1.82%	1
2022 Q4	$73.8M	Buy	+648,672	New	+$53.9M	1.46%	2
2022 Q3	–	Sell	-11,812	Closed	-$942K	–	2860
2022 Q2	$942K	Buy	+11,812	New	+$1.12M	0.02%	926
2022 Q1	–	Sell	-3,152	Closed	-$340K	–	2919
2021 Q4	$340K	Buy	+3,152	New	+$344K	0.01%	1761
2020 Q4	–	Sell	-15,166	Closed	-$1.18M	–	1764
2020 Q3	$1.18M	Buy	+15,166	New	+$1.04M	0.05%	508
2020 Q2	–	Sell	-27,757	Closed	-$822K	–	1529
2020 Q1	$822K	Buy	+27,757	New	+$939K	0.07%	308
2019 Q4	–	Sell	-21,044	Closed	-$573K	–	1500
2019 Q3	$573K	Sell	21,044 -129,940	-86%	-$3.36M	0.02%	677
2019 Q2	$3.63M	Sell	150,984 -20,541	-12%	-$521K	0.1%	154
2019 Q1	$4.53M	Buy	171,525 +39,309	+30%	+$931K	0.19%	111
2018 Q4	$2.58M	Buy	132,216 +46,125	+54%	+$904K	0.05%	145
2018 Q3	$1.69M	Buy	+86,091	New	+$1.64M	0.04%	322
2018 Q2	–	Sell	-137,592	Closed	-$1.95M	–	1329
2018 Q1	$1.95M	Buy	137,592 +41,034	+42%	+$606K	0.06%	167
2017 Q4	$1.41M	Buy	96,558 +70,870	+276%	+$995K	0.04%	261
2017 Q3	$326K	Buy	+25,688	New	+$327K	0.01%	800
2017 Q2	–	Sell	-20,100	Closed	-$297K	–	1540
2017 Q1	$297K	Sell	20,100 -83,975	-81%	-$1.36M	0.01%	1010
2016 Q4	$1.68M	Buy	104,075 +54,470	+110%	+$988K	0.04%	210
2016 Q3	$899K	Buy	+49,605	New	+$969K	0.02%	450
2016 Q2	–	Sell	-72,983	Closed	-$1.21M	–	2053
2016 Q1	$1.21M	Buy	72,983 +24,413	+50%	+$427K	0.03%	429
2015 Q4	$1.05M	Buy	48,570 +36,532	+303%	+$711K	0.03%	424
2015 Q3	$239K	Sell	12,038 -125,362	-91%	-$3.96M	0.01%	1233
2015 Q2	$4.77M	Buy	137,400 +91,892	+202%	+$2.8M	0.14%	105
2015 Q1	$1.18M	Sell	45,508 -229,069	-83%	-$4.2M	0.04%	309
2014 Q4	$3.54M	Sell	274,577 -20,237	-7%	-$253K	0.12%	92
2014 Q3	$3.62M	Buy	+294,814	New	+$3.43M	0.13%	88
2014 Q2	–	Sell	-16,733	Closed	-$253K	–	1412
2014 Q1	$253K	Buy	16,733 +2,087	+14%	+$23.6K	0.01%	921
2013 Q4	$112K	Buy	+14,646	New	+$79K	0.01%	1195

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tudor Investment Corp's HZNP Position: Q4 2023 in Review

Tudor Investment Corp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,303,844 shares — an estimated $151M sold.

Tudor Investment Corp first reported a position in HZNP in Q4 2013 and held it in 28 quarters. The position peaked at $151M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Tudor Investment Corp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Tudor Investment Corp sold 1,303,844 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $151M.
Tudor Investment Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 28 quarters.
Tudor Investment Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $151M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.